GB9011861D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB9011861D0 GB9011861D0 GB9011861A GB9011861A GB9011861D0 GB 9011861 D0 GB9011861 D0 GB 9011861D0 GB 9011861 A GB9011861 A GB 9011861A GB 9011861 A GB9011861 A GB 9011861A GB 9011861 D0 GB9011861 D0 GB 9011861D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9011861A GB9011861D0 (en) | 1990-05-26 | 1990-05-26 | Novel compounds |
PCT/GB1991/000801 WO1991018989A1 (en) | 1990-05-26 | 1991-05-21 | Hybrid plasminogen activator mutants |
AU78745/91A AU7874591A (en) | 1990-05-26 | 1991-05-21 | Hybrid plasminogen activator mutants |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9011861A GB9011861D0 (en) | 1990-05-26 | 1990-05-26 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9011861D0 true GB9011861D0 (en) | 1990-07-18 |
Family
ID=10676651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9011861A Pending GB9011861D0 (en) | 1990-05-26 | 1990-05-26 | Novel compounds |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU7874591A (en) |
GB (1) | GB9011861D0 (en) |
WO (1) | WO1991018989A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6537776B1 (en) | 1999-06-14 | 2003-03-25 | Diversa Corporation | Synthetic ligation reassembly in directed evolution |
US6465424B1 (en) * | 1999-02-17 | 2002-10-15 | Bristol-Myers Squibb Company | Anti-angiogenic agent and method for inhibiting angiogenesis |
US7094579B2 (en) | 2002-02-13 | 2006-08-22 | Xoma Technology Ltd. | Eukaryotic signal sequences for prokaryotic expression |
EP1947116B1 (en) | 2003-02-10 | 2017-06-21 | 2-BBB Medicines B.V. | Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
WO2010087702A1 (en) | 2009-01-30 | 2010-08-05 | Stichting Katholieke Universiteit | TET2 gene as a marker for diagnosing a myelodysuplastic syndrome (MDS) or an acute myeloid leukemia (AML) and determining the prognosis in a subject |
WO2011034421A1 (en) | 2009-09-16 | 2011-03-24 | Stichting Het Nederlands Kanker Instituut | Fra-1 target genes as drug targets for treating cancer |
EP2305717A1 (en) | 2009-09-21 | 2011-04-06 | Koninklijke Nederlandse Akademie van Wetenschappen | Inhibiting TNIK for treating colon cancer |
US9598692B2 (en) | 2009-09-25 | 2017-03-21 | University Of Oslo | Multivalent phage display systems and methods |
EP2354244A1 (en) | 2010-02-04 | 2011-08-10 | Stichting Top Institute Food and Nutrition | MBL2 as a marker of liver-specific insulin resistance |
EP2354245A1 (en) | 2010-02-04 | 2011-08-10 | Stichting Top Institute Food and Nutrition | MBL2 as a marker of hepatic PPAR- activity |
WO2012047324A2 (en) | 2010-06-10 | 2012-04-12 | President And Fellows Of Harvard College | Systems and methods for amplification and phage display |
CA2808998A1 (en) | 2010-08-17 | 2012-02-23 | Stichting Katholieke Universiteit | A novel method for diagnosing q-fever using a cellular immunological test |
WO2012039614A1 (en) | 2010-09-21 | 2012-03-29 | Stichting Katholieke Universiteit | Novel method for diagnosing lyme disease using a cellular immunological test |
EP2465928A1 (en) | 2010-12-16 | 2012-06-20 | Academisch Medisch Centrum bij de Universiteit van Amsterdam | Treatment of Th17-mediated diseases |
WO2014142646A1 (en) | 2013-03-13 | 2014-09-18 | Stichting Katholieke Universiteit | Q-fever diagnostic |
JP2016524697A (en) | 2013-05-02 | 2016-08-18 | スティッチング カソリーケ ウニベルシテイトStichting Katholieke Universiteit | Personalized medicine |
WO2016168755A1 (en) | 2015-04-17 | 2016-10-20 | Distributed Bio, Inc. | Method for mass humanization of non-human antibodies |
WO2016173719A1 (en) | 2015-04-30 | 2016-11-03 | Abcheck S.R.O. | Method for mass humanization of rabbit antibodies |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ191320A (en) * | 1978-09-07 | 1982-09-14 | Beecham Group Ltd | In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions |
EP0297882B1 (en) * | 1987-07-01 | 1993-08-25 | Beecham Group Plc | Hybrid plasminogen activators |
ATE226636T1 (en) * | 1989-03-06 | 2002-11-15 | Univ Texas | SERPIN RESISTANT T-PA; MUTANTS; GENE |
-
1990
- 1990-05-26 GB GB9011861A patent/GB9011861D0/en active Pending
-
1991
- 1991-05-21 AU AU78745/91A patent/AU7874591A/en not_active Abandoned
- 1991-05-21 WO PCT/GB1991/000801 patent/WO1991018989A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1991018989A1 (en) | 1991-12-12 |
AU7874591A (en) | 1991-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9007762D0 (en) | Novel compounds | |
GB9009542D0 (en) | Novel compounds | |
AP9100305A0 (en) | Novel compounds | |
GB9011861D0 (en) | Novel compounds | |
GB9000846D0 (en) | Novel compounds | |
GB9008078D0 (en) | Novel compounds | |
GB9005737D0 (en) | Novel compounds | |
GB9008065D0 (en) | Novel compounds | |
GB9010296D0 (en) | Novel compounds | |
GB9006728D0 (en) | Novel compounds | |
GB9011656D0 (en) | Novel compounds | |
GB9010264D0 (en) | Novel compounds | |
GB9010299D0 (en) | Novel compounds | |
GB9009604D0 (en) | Novel compounds | |
GB9009543D0 (en) | Novel compounds | |
GB9010265D0 (en) | Novel compounds | |
GB9009309D0 (en) | Novel compounds | |
GB9009214D0 (en) | Novel compounds | |
GB9008826D0 (en) | Novel compounds | |
GB9008451D0 (en) | Novel compounds | |
GB9008353D0 (en) | Novel compounds | |
GB9008106D0 (en) | Novel compounds | |
GB9008094D0 (en) | Novel compounds | |
GB9008093D0 (en) | Novel compounds | |
GB9008079D0 (en) | Novel compounds |